Peregrine Pharmaceuticals | 资产

Assets 更改 日
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Celldex Therapeutics USD 465.63M 185.37M 2023-12
MannKind USD 475.2M 154.87M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Xencor USD 952.69M 174.26M 2023-12



Peregrine Pharmaceuticals 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.